Berenberg Bank set a €121.00 ($144.05) target price on Bayer AG (FRA:BAYN) in a research note published on Tuesday. The firm currently has a neutral rating on the healthcare company’s stock.

A number of other analysts have also recently weighed in on the stock. J P Morgan Chase & Co reissued a buy rating on shares of Bayer AG in a report on Tuesday. HSBC Holdings plc set a €105.00 ($125.00) price objective on shares of Bayer AG and gave the stock a neutral rating in a report on Tuesday. UBS AG set a €125.00 ($148.81) price objective on shares of Bayer AG and gave the stock a buy rating in a report on Tuesday. Jefferies Group LLC set a €137.00 ($163.10) price objective on shares of Bayer AG and gave the stock a buy rating in a report on Tuesday. Finally, Deutsche Bank AG set a €124.00 ($147.62) target price on shares of Bayer AG and gave the company a buy rating in a report on Monday, August 28th. Nine research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The stock currently has a consensus rating of Buy and a consensus price target of €119.64 ($142.42).

Bayer AG (BAYN) opened at 108.358 on Tuesday. The firm’s 50-day moving average is €108.49 and its 200-day moving average is €110.98. The firm has a market cap of €94.50 billion and a price-to-earnings ratio of 18.744. Bayer AG has a 52 week low of €85.72 and a 52 week high of €123.83.

COPYRIGHT VIOLATION WARNING: “Bayer AG (BAYN) Given a €121.00 Price Target by Berenberg Bank Analysts” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/09/02/bayer-ag-bayn-given-a-121-00-price-target-by-berenberg-bank-analysts.html.

Bayer AG Company Profile

.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Stock Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related stocks with our FREE daily email newsletter.